Patent Assignment
Reel/Frame 064009/0261
Corrective Assignment to Correct the Seller's Name and Execution Date Previously Recorded on Reel 032675 Frame 0936. Assignor(S) Hereby Confirms the Seller's Name Should Read Savient Pharma Holdings, Inc. and the Execution Date for Both Parties Should Read 01/09/2014.
Recorded: 2023-06-16
Pages: 26
Assignors
SAVIENT PHARMACEUTICALS, INC.
Executed: 2014-01-09
SAVIENT PHARMA HOLDINGS, INC.
Executed: 2014-01-09
Assignee
CREALTA PHARMACEUTICALS LLC
150 S. SAUNDERS RD., SUITE 130, LAKE FOREST, ILLINOIS, 60045
Covered Properties
(17)
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
Application:
11/899,688 →
Publication:
US 2008/0159976
Purification of Proteins With Cationic Surfactant
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Purification of proteins with cationic surfactant
Application:
60/670,520 →
Variant form of urate oxidase and use thereof
Application:
60/670,541 →
Variant forms of urate oxidase and use thereof
Application:
60/670,573 →
Routine Serum Uric Acid (SUA) Monitoring Predicts Antibody-Mediated Loss of Response and Infusion Reaction Risk During Pegloticase Therapy
Application:
61/248,698 →
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegloticase Therapy
Application:
61/298,718 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 11, 2005
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 016472/0839 →
Assignment of Assignor's Interest
Apr 11, 2005
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 016476/0554 →
Assignment of Assignor's Interest
Apr 11, 2005
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 016472/0846 →
Assignment of Assignor's Interest
Jan 18, 2008
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020383/0946 →
Assignment of Assignor's Interest
Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020386/0145 →
Assignment of Assignor's Interest
Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020384/0974 →
Assignment of Assignor's Interest
Mar 14, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA; REHRIG, CLAUDIA D.; HUANG, WILLIAM
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020651/0468 →
Security Agreement
Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Assignment of Assignor's Interest
Aug 3, 2012
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 028715/0585 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →
Security Agreement
Feb 21, 2014
From: CREALTA PHARMACEUTICALS LLC
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 032319/0077 →
Security Agreement
Mar 4, 2014
From: CREALTA PHARMACEUTICALS LLC
To: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
Reel/Frame 032384/0285 →
Assignment of Assignor's Interest
Apr 15, 2014
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, LLC
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 032675/0936 →
Release of Security Interest
Jan 13, 2016
From: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0049 →
Release of Security Interest
Jan 13, 2016
From: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0148 →
Change of Name
Jul 5, 2016
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 039258/0154 →
Change of Name
Jul 5, 2016
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 039258/0152 →
Patent Security Agreement
Sep 16, 2016
From: HORIZON PHARMA RHEUMATOLOGY LLC (FORMERLY KNOWN AS CREALTA PHARMACEUTICALS LLC)
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040059/0007 →
Change of Name
Nov 18, 2016
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 040648/0361 →
Change of Name
Nov 18, 2016
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 040648/0367 →
Assignment of Assignor's Interest
Sep 7, 2022
From: HORIZON THERAPEUTICS USA, INC.
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 061389/0471 →
Assignment of Assignor's Interest
Oct 31, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC
Reel/Frame 061805/0076 →
Corrective Assignment to Correct the Assignor and Assignee Names on the Cover Sheet Previously Recorded at Reel: 061389 Frame: 0471. Assignor(S) Hereby Confirms the Assignment.
Dec 1, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062075/0251 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment.
Dec 1, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062073/0930 →
Assignment of Assignor's Interest
Dec 22, 2022
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 062191/0611 →